888-776-0942 from 8 AM - 10 PM ET
Allē Double Point Promotion Encourages Consumers to See the JUVÉDERM® Difference
IRVINE, Calif. , Aug. 17, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), invites consumers to experience the JUVÉDERM® difference. The JUVÉDERM® Collection of Fillers is the number one selling collection of dermal fillers on the market and offers the largest portfolio of fillers specifically designed for different areas of the face to address key patient concerns, enabling a customized treatment approach.1 Injectable dermal fillers are highly sought-after treatments among consumers who are looking to address key signs of aging or to simply accentuate what is already naturally theirs.
Right now, consumers can earn double points in Allē, Allergan Aesthetics' loyalty rewards program, when treated with two or three syringes from the JUVÉDERM® Collection of Fillers during the same visit. Allē points can be redeemed for future Allē-eligible treatments or products. The promotion runs through Friday, September 30, 2022 . Allē members can also use the Allē Flash program to determine if they are eligible for additional savings.
"We estimate that in the U.S., 20 million consumers are interested in receiving treatment with a dermal filler in the next two years.2 We help support and grow the filler market while ensuring that all consumers who are interested in talking to their specialist about treatment with the JUVÉDERM® Collection of Fillers have access to education and the product. Recently, we launched a YouTube channel to provide deeper patient education and it has more than five million views since launch," said Carrie Strom , Global President Allergan Aesthetics. "The JUVÉDERM® Collection of Fillers is the number one chosen dermal filler collection in the U.S. and approved for all skin tones.1, 3-5 We are excited to share our passion for the JUVÉDERM® Collection of Fillers with consumers through this limited time offer. We invite them to talk to their specialist and experience the JUVÉDERM® difference for themselves."
The JUVÉDERM® difference is achieved with a wide range of minimally invasive treatment options that provides instant results that are long-lasting and natural-looking.6-12 Additionally, the JUVÉDERM® Collection of Fillers' VYCROSS® technology is the number one chosen dermal filler technology worldwide.1 As the number one chosen dermal filler collection worldwide, JUVÉDERM® boasts the top chosen fillers for cheeks (JUVÉDERM® VOLUMA® XC), lower face wrinkles and folds (JUVÉDERM® Ultra Plus XC and JUVÉDERM® VOLLURE® XC), lips (JUVÉDERM® Ultra XC and JUVÉDERM® VOLBELLA® XC), and perioral lines (JUVÉDERM® VOLBELLA® XC).1
"I use the full JUVÉDERM® Collection of Fillers to achieve optimal aesthetic outcomes for my patients," said Dr. Deborah Sherman , board certified, fellowship trained ophthalmic plastic surgeon and master injector. "As one of the longest standing filler manufacturers in the industry, it's a brand I trust due to the years of clinical studies and safety data available to help me feel confident in the product I'm offering to my patients. Even the JUVÉDERM® syringe itself is innovative – it's the first and only certified ergonomic syringe that helps minimize hand fatigue so I can comfortably treat patients all day long. JUVÉDERM® enables me to offer my patients a suite of premium products that deliver smooth, natural-looking, and long-lasting results6-12 so my patients keep coming back time and again."
About the JUVÉDERM® Double Points Promotion Consumers can experience the JUVÉDERM® difference while earning double points in Allē towards a future JUVÉDERM® or other Allē eligible treatment when treated with two or three syringes from the JUVÉDERM® Collection of Fillers during the same visit through Friday, September 30, 2022 . Consumers who take the challenge and experience the JUVÉDERM® difference will be treated with products that are:
Consumers are encouraged to enroll in Allē to unlock access to the current promotion, subject to applicable program terms and conditions. Allē is the first and only loyalty program in the aesthetics market to also offer consumers the ability to earn points on over 40 non-Allergan Aesthetics treatments and brands. To learn more about Allē, visit Alle.com.
For more information on the JUVÉDERM® Collection of Fillers, visit Juvéderm.com, follow @JUVÉDERM on Instagram and subscribe to the JUVÉDERM® Collection of Fillers channel on YouTube.
About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.AllerganAesthetics.com.
About AbbVie AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
JUVÉDERM® Injectable Gel Fillers Important Information
JUVÉDERM® VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to improve the chin profile in adults over 21.
JUVÉDERM® VOLUX™ XC injectable gel is for deep injection to improve moderate to severe loss of jawline definition in adults over the age of 21.
JUVÉDERM® VOLLURE® XC, JUVÉDERM® Ultra Plus XC, and JUVÉDERM® Ultra XC injectable gels are for injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. JUVÉDERM® VOLLURE® XC injectable gel is for adults over 21.
JUVÉDERM® Ultra XC injectable gel is also for injection into the lips and perioral area for lip augmentation in adults over 21.
JUVÉDERM® VOLBELLA® XC injectable gel is indicated for injection into the lips for lip augmentation and correction of perioral lines, and for injection into the undereye hollows to improve the appearance of undereye hollows in adults over the age of 21.
Are there any reasons why I should not receive any JUVÉDERM® formulation? Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or the Gram-positive bacterial proteins used in these products, or if you have had previous allergic reactions to hyaluronic acid fillers.
What warnings should my doctor advise me about?
What precautions should my doctor advise me about?
What are possible side effects of treatment? The most commonly reported side effects with JUVÉDERM® injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM® VOLBELLA® XC, dryness was also reported.
These side effects are consistent with other facial injection procedures, and most will resolve with time. Your doctor may choose to treat side effects persisting over 30 days with antibiotics, steroids, or hyaluronidase (an enzyme that breaks down hyaluronic acid).
As with all skin injection procedures, there is a risk of infection.
To report a side effect with any product in the JUVÉDERM® Collection, please call the Allergan® Product Support Department at 1‑877‑345‑5372. Please also visit Juvederm.com or talk to your doctor for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician or properly licensed practitioner.
Cision Distribution 888-776-0942 from 8 AM - 9 PM ET